Trial Profile
Role of Exogenous and Endogenous Sex Hormones on Tenofovir and Emtricitabine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Apr 2024
Price :
$35
*
At a glance
- Drugs Emtricitabine (Primary) ; Tenofovir (Primary)
- Indications HIV infections; Vaginal diseases
- Focus Pharmacokinetics
- 12 Apr 2024 Status changed from recruiting to completed.
- 06 Apr 2023 Planned End Date changed from 30 Jan 2023 to 30 Jan 2024.
- 06 Apr 2023 Planned primary completion date changed from 30 Jan 2023 to 30 Jan 2024.